Prevention Research Consortium Corp is a 501(c)(3) nonprofit organization dedicated to reducing the global burden of dementia.
Our vision is to combine genomic, fluid, EEG, and EMR biomarkers to build a risk-assessment model that accurately predicts the incidence and stage of mild cognitive impairment due to multiple causes, particularly late-onset Alzheimer's disease (LOAD). The use of computational models that incorporate comorbidity and all-cause adult dementia prediction is central to our multi-site, international study plan.
We aim to deliver clinical validation of biomarker models that identify high-risk pre-LOAD individuals 5–10 years before plasma brain-derived pTau217 signals AD predementia—well before cognitive symptoms emerge. Findings from our international, multi-site study could transform early intervention strategies in dementia care.
Our members include an interdisciplinary team of genomics experts, proteomic specialists, neurologists, psychiatrists, primary care providers, caregivers, dementia patients, digital technologists, bioinfomaticians, AI specialists, and generalists.
